triazoles has been researched along with Prediabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bermúdez-Silva, FJ; Cobo-Vuilleumier, N; Espinosa-Jiménez, V; Gauthier, BR; Gómez-Conde, AI; Persaud, SJ; Rafacho, A; Romero-Zerbo, SY; Ruz-Maldonado, I; Sánchez-Salido, L; Tinahones, FJ | 1 |
| Fang, F; Han, X; Li, Y; Liu, Y; Lu, Y; Pei, Y; Shu, H; Sun, B; Tian, H; Xiao, J; Zhong, W | 1 |
| Johnson, JL; Kim, MK; O'Neal, KS; Pack, CC | 1 |
3 other study(ies) available for triazoles and Prediabetes
| Article | Year |
|---|---|
The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice.
Topics: Animals; Anxiety; Behavior, Animal; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Inflammation Mediators; Insulin; Islets of Langerhans; Liver; Mice, Inbred C57BL; Obesity; Prediabetic State; Receptor, Cannabinoid, CB1; Triazoles | 2017 |
The DPP-4 inhibitor MK0626 and exercise protect islet function in early pre-diabetic kkay mice.
Topics: Animals; Dipeptidyl-Peptidase IV Inhibitors; Islets of Langerhans; Mice; Mice, Inbred C57BL; Physical Conditioning, Animal; Prediabetic State; Triazoles | 2013 |
Management of a prediabetes case with the DPP-4 inhibitor sitagliptin.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Middle Aged; Prediabetic State; Pyrazines; Sitagliptin Phosphate; Triazoles | 2014 |